FMA
AVEO

FNY Managed Accounts’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

FNY Managed Accounts’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1K Buy
+50
New +$1.46K ﹤0.01% 569
2015
Q2 		– Sell
-1,250
Closed -$18.1K – 630
2015
Q1 		$18.1K Buy
+1,250
New +$13.7K 0.01% 182

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

FNY Managed Accounts's AVEO Position: Q1 2018 in Review

FNY Managed Accounts opened a new position in AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2018: 50 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #569 among its holdings. This is a return to the name: FNY Managed Accounts previously reported a position in AVEO as recently as Q1 2015.

FNY Managed Accounts first reported a position in AVEO in Q1 2015 and has held it in 2 quarters since. The position peaked at $18.1K in Q1 2015. 90 funds tracked by Wall St. Rank hold AVEO as of Q1 2018.

  • FNY Managed Accounts held 50 shares of AVEO Pharmaceuticals, Inc. worth $1K as of Q1 2018.
  • AVEO Pharmaceuticals, Inc. was a new FNY Managed Accounts position in Q1 2018.
  • AVEO Pharmaceuticals, Inc. made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #569 holding.
  • FNY Managed Accounts first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2015 and has held it in 2 quarters since.
  • FNY Managed Accounts's AVEO Pharmaceuticals, Inc. position peaked at $18.1K in Q1 2015.
  • 90 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.